[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 2,329
Citations 0
Correction
December 11, 2018

Missing Conflict of Interest Disclosure

JAMA. 2018;320(22):2381. doi:10.1001/jama.2018.17511

In the Preliminary Communication titled “Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing,”1 published in the September 5, 2017, issue of JAMA, conflict of interest disclosures were not reported accurately by José Baselga, MD, PhD. Dr Baselga has written a Letter to the journal2 explaining this inconsistent reporting of potential conflict of interest disclosures. This article was corrected online.

References
1.
Mandelker  D, Zhang  L, Kemel  Y,  et al.  Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing.  JAMA. 2017;318(9):825-835. doi:10.1001/jama.2017.11137PubMedGoogle ScholarCrossref
2.
Baselga  J.  Failure to disclose conflict of interest in article published in JAMA on detection of cancer-related genes  [published October 26, 2018].  JAMA. doi:10.1001/jama.2018.16961Google Scholar
×